Global Nucleotide Premix Market Research Report 2023

Publication ID:

PB502230837

Publication Date:

February 15, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Nucleotides are conditionally essential nutrients that are one of the structural component or building block of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). Nucleotide is consist of a molecule of sugar and one of phosphoric acid plus a base (one of four chemicals: guanine, adenine, cytosine, and thymine). Premix is usually referred to a product or substance that is mixed in an early stage in the manufacturing process. Premixes are used to enrich products and enhance product formula. Nucleotide premixes are the customized blend of nucleotides and other nutrients that are used in the food and beverages fortification.听
The global Nucleotide Premix market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Nucleotide Premix is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nucleotide Premix is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Nucleotide Premix include Vitablend Nederland B.V, Koninklijke DSM N.V, Glanbia plc, Cargill, Inc, Watson Inc, Corbion Purac, Jubilant Life Sciences, Nanjing Biotogether Co. Ltd and BioAtlas, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nucleotide Premix, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleotide Premix.
The Nucleotide Premix market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nucleotide Premix market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleotide Premix manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Vitablend Nederland B.V
Koninklijke DSM N.V
Glanbia plc
Cargill, Inc
Watson Inc
Corbion Purac
Jubilant Life Sciences
Nanjing Biotogether Co. Ltd
BioAtlas
Premier Research Labs
Segment by Type
Liquid
Powder
Segment by Application
Food & Beverage
Nutritional Drinks
Infant Formula
Sports Nutrition
Dietary Supplement
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nucleotide Premix manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Nucleotide Premix by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Nucleotide Premix in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Nucleotide Premix Market Overview
1.1 Product Definition
1.2 Nucleotide Premix Segment by Type
1.2.1 Global Nucleotide Premix Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Liquid
1.2.3 Powder
1.3 Nucleotide Premix Segment by Application
1.3.1 Global Nucleotide Premix Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Food & Beverage
1.3.3 Nutritional Drinks
1.3.4 Infant Formula
1.3.5 Sports Nutrition
1.3.6 Dietary Supplement
1.4 Global Market Growth Prospects
1.4.1 Global Nucleotide Premix Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Nucleotide Premix Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Nucleotide Premix Production Estimates and Forecasts (2018-2029)
1.4.4 Global Nucleotide Premix Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Nucleotide Premix Production Market Share by Manufacturers (2018-2023)
2.2 Global Nucleotide Premix Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Nucleotide Premix, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Nucleotide Premix Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Nucleotide Premix Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Nucleotide Premix, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Nucleotide Premix, Product Offered and Application
2.8 Global Key Manufacturers of Nucleotide Premix, Date of Enter into This Industry
2.9 Nucleotide Premix Market Competitive Situation and Trends
2.9.1 Nucleotide Premix Market Concentration Rate
2.9.2 Global 5 and 10 Largest Nucleotide Premix Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Nucleotide Premix Production by Region
3.1 Global Nucleotide Premix Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Nucleotide Premix Production Value by Region (2018-2029)
3.2.1 Global Nucleotide Premix Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Nucleotide Premix by Region (2024-2029)
3.3 Global Nucleotide Premix Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Nucleotide Premix Production by Region (2018-2029)
3.4.1 Global Nucleotide Premix Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Nucleotide Premix by Region (2024-2029)
3.5 Global Nucleotide Premix Market Price Analysis by Region (2018-2023)
3.6 Global Nucleotide Premix Production and Value, Year-over-Year Growth
3.6.1 North America Nucleotide Premix Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Nucleotide Premix Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Nucleotide Premix Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Nucleotide Premix Production Value Estimates and Forecasts (2018-2029)
3.6.5 India Nucleotide Premix Production Value Estimates and Forecasts (2018-2029)
4 Nucleotide Premix Consumption by Region
4.1 Global Nucleotide Premix Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Nucleotide Premix Consumption by Region (2018-2029)
4.2.1 Global Nucleotide Premix Consumption by Region (2018-2023)
4.2.2 Global Nucleotide Premix Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Nucleotide Premix Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Nucleotide Premix Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Nucleotide Premix Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Nucleotide Premix Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Nucleotide Premix Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Nucleotide Premix Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Nucleotide Premix Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Nucleotide Premix Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Nucleotide Premix Production by Type (2018-2029)
5.1.1 Global Nucleotide Premix Production by Type (2018-2023)
5.1.2 Global Nucleotide Premix Production by Type (2024-2029)
5.1.3 Global Nucleotide Premix Production Market Share by Type (2018-2029)
5.2 Global Nucleotide Premix Production Value by Type (2018-2029)
5.2.1 Global Nucleotide Premix Production Value by Type (2018-2023)
5.2.2 Global Nucleotide Premix Production Value by Type (2024-2029)
5.2.3 Global Nucleotide Premix Production Value Market Share by Type (2018-2029)
5.3 Global Nucleotide Premix Price by Type (2018-2029)
6 Segment by Application
6.1 Global Nucleotide Premix Production by Application (2018-2029)
6.1.1 Global Nucleotide Premix Production by Application (2018-2023)
6.1.2 Global Nucleotide Premix Production by Application (2024-2029)
6.1.3 Global Nucleotide Premix Production Market Share by Application (2018-2029)
6.2 Global Nucleotide Premix Production Value by Application (2018-2029)
6.2.1 Global Nucleotide Premix Production Value by Application (2018-2023)
6.2.2 Global Nucleotide Premix Production Value by Application (2024-2029)
6.2.3 Global Nucleotide Premix Production Value Market Share by Application (2018-2029)
6.3 Global Nucleotide Premix Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Vitablend Nederland B.V
7.1.1 Vitablend Nederland B.V Nucleotide Premix Corporation Information
7.1.2 Vitablend Nederland B.V Nucleotide Premix Product Portfolio
7.1.3 Vitablend Nederland B.V Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Vitablend Nederland B.V Main Business and Markets Served
7.1.5 Vitablend Nederland B.V Recent Developments/Updates
7.2 Koninklijke DSM N.V
7.2.1 Koninklijke DSM N.V Nucleotide Premix Corporation Information
7.2.2 Koninklijke DSM N.V Nucleotide Premix Product Portfolio
7.2.3 Koninklijke DSM N.V Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Koninklijke DSM N.V Main Business and Markets Served
7.2.5 Koninklijke DSM N.V Recent Developments/Updates
7.3 Glanbia plc
7.3.1 Glanbia plc Nucleotide Premix Corporation Information
7.3.2 Glanbia plc Nucleotide Premix Product Portfolio
7.3.3 Glanbia plc Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Glanbia plc Main Business and Markets Served
7.3.5 Glanbia plc Recent Developments/Updates
7.4 Cargill, Inc
7.4.1 Cargill, Inc Nucleotide Premix Corporation Information
7.4.2 Cargill, Inc Nucleotide Premix Product Portfolio
7.4.3 Cargill, Inc Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Cargill, Inc Main Business and Markets Served
7.4.5 Cargill, Inc Recent Developments/Updates
7.5 Watson Inc
7.5.1 Watson Inc Nucleotide Premix Corporation Information
7.5.2 Watson Inc Nucleotide Premix Product Portfolio
7.5.3 Watson Inc Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Watson Inc Main Business and Markets Served
7.5.5 Watson Inc Recent Developments/Updates
7.6 Corbion Purac
7.6.1 Corbion Purac Nucleotide Premix Corporation Information
7.6.2 Corbion Purac Nucleotide Premix Product Portfolio
7.6.3 Corbion Purac Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Corbion Purac Main Business and Markets Served
7.6.5 Corbion Purac Recent Developments/Updates
7.7 Jubilant Life Sciences
7.7.1 Jubilant Life Sciences Nucleotide Premix Corporation Information
7.7.2 Jubilant Life Sciences Nucleotide Premix Product Portfolio
7.7.3 Jubilant Life Sciences Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Jubilant Life Sciences Main Business and Markets Served
7.7.5 Jubilant Life Sciences Recent Developments/Updates
7.8 Nanjing Biotogether Co. Ltd
7.8.1 Nanjing Biotogether Co. Ltd Nucleotide Premix Corporation Information
7.8.2 Nanjing Biotogether Co. Ltd Nucleotide Premix Product Portfolio
7.8.3 Nanjing Biotogether Co. Ltd Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Nanjing Biotogether Co. Ltd Main Business and Markets Served
7.7.5 Nanjing Biotogether Co. Ltd Recent Developments/Updates
7.9 BioAtlas
7.9.1 BioAtlas Nucleotide Premix Corporation Information
7.9.2 BioAtlas Nucleotide Premix Product Portfolio
7.9.3 BioAtlas Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.9.4 BioAtlas Main Business and Markets Served
7.9.5 BioAtlas Recent Developments/Updates
7.10 Premier Research Labs
7.10.1 Premier Research Labs Nucleotide Premix Corporation Information
7.10.2 Premier Research Labs Nucleotide Premix Product Portfolio
7.10.3 Premier Research Labs Nucleotide Premix Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Premier Research Labs Main Business and Markets Served
7.10.5 Premier Research Labs Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Nucleotide Premix Industry Chain Analysis
8.2 Nucleotide Premix Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Nucleotide Premix Production Mode & Process
8.4 Nucleotide Premix Sales and Marketing
8.4.1 Nucleotide Premix Sales Channels
8.4.2 Nucleotide Premix Distributors
8.5 Nucleotide Premix Customers
9 Nucleotide Premix Market Dynamics
9.1 Nucleotide Premix Industry Trends
9.2 Nucleotide Premix Market Drivers
9.3 Nucleotide Premix Market Challenges
9.4 Nucleotide Premix Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Vitablend Nederland B.V
Koninklijke DSM N.V
Glanbia plc
Cargill, Inc
Watson Inc
Corbion Purac
Jubilant Life Sciences
Nanjing Biotogether Co. Ltd
BioAtlas
Premier Research Labs

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂